Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

7 treatments under study, led by Dsoc Endoscopist Experts Classification

Research Leaders

12 sponsors active, led by Erasmus Medical Center

Related Conditions

Often studied with 16 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 6 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (3)

Trial Status

Completed4
Unknown1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 4 completed trials

Clinical Trials (6)

Research Network

Common Treatments

  • Dsoc Endoscopist Experts Classification1
  • Endoscopic Ultrasound Registration1
  • Dexamethasone1
  • Preoperative Hyperbaric Oxygen1
  • Registration Of All Findings During Preoperative Endoscopic Ultrasound1

Active Sponsors

  • Erasmus Medical Center2
  • Advanced Endoscopy Research, Robert Wood Johnson Medical School Rutgers University1
  • Universitair Ziekenhuis Brussel1
  • Baylor St. Luke's Medical Center1
  • Instituto Ecuatoriano de Enfermedades Digestivas1

Top Investigators

Related Conditions

  • Cholangiocarcinoma2
  • Hilar Cholangiocarcinoma2
  • Cholestasis1
  • Intrahepatic Cholangiocarcinoma Icc1
  • Duodenal Neoplasms1

Activity Timeline